Minerva Neurosciences Announces Listing Transfer to Nasdaq Capital Market
BURLINGTON, Mass., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical ...
Read moreBURLINGTON, Mass., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical ...
Read moreA Porsche 911 Carrera 4S stands in the evening light in a drive-in cinema on the ...
Read moreSAN DIEGO, Sept. 2, 2022 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, ...
Read moreMORRISVILLE, N.C., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant ...
Read moreBRISBANE, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company ...
Read moreViridian Therapeutics, IncWALTHAM, Mass., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the ...
Read morePARSIPPANY, N.J.--(BUSINESS WIRE)--IVERIC bio, Inc. (NASDAQ: ISEE) today reported that on August 1, 2022, the Company ...
Read moreREDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical-stage biotechnology company discovering and ...
Read moreA man walks past the Alibaba Group office building in Beijing, China August 9, 2021. REUTERS/Tingshu ...
Read moreEvidently unfazed by the state of the stock exchanges and IPO market, FaZe Clan went public ...
Read more© 2022 TheDailyStock.News